The Latest News

Matt DeLisa, David Putnam, and Gary Whittaker in the lab

Universal flu vaccine developed at Cornell nearing human trials

A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases. Read more

Faculty profiles, fall 2019

From food waste reduction to secrets found in medical imaging data, Elena Belavina, Charles Danko, Leslie Lok and Mert Sabuncu bring their expertise to Cornell. Read more